 Connection
Jason Glanz to Diphtheria-Tetanus-Pertussis Vaccine
This is a "connection" page, showing publications Jason Glanz has written about Diphtheria-Tetanus-Pertussis Vaccine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.318 |
|
|
|
-
Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M. Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):405-412.
Score: 0.137
-
Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.105
-
Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM. Risk of immune hemolytic anemia in children following immunization. Vaccine. 2009 Dec 09; 27(52):7394-7.
Score: 0.076
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|